Artificial Pancreas - Medical Devices Pipeline Assessment, 2017

  • ID: 4370589
  • Drug Pipelines
  • 124 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Admetsys Corporation
  • Animas Corp
  • Beta Bionics Inc
  • Beta-O2 Technologies Ltd
  • Bigfoot Biomedical, Inc.
  • BioTex Inc
  • MORE
Artificial Pancreas - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Artificial Pancreas - Medical Devices Pipeline Assessment, 2017" provides an overview of Artificial Pancreas currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Artificial Pancreas pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Artificial Pancreas under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Artificial Pancreas under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Admetsys Corporation
  • Animas Corp
  • Beta Bionics Inc
  • Beta-O2 Technologies Ltd
  • Bigfoot Biomedical, Inc.
  • BioTex Inc
  • MORE
1.1 List of Tables
1.2 List of Figures

2. Introduction
2.1 Artificial Pancreas Overview

3. Products under Development
3.1 Artificial Pancreas - Pipeline Products by Stage of Development
3.2 Artificial Pancreas - Pipeline Products by Territory
3.3 Artificial Pancreas - Pipeline Products by Regulatory Path
3.4 Artificial Pancreas - Pipeline Products by Estimated Approval Date
3.5 Artificial Pancreas - Ongoing Clinical Trials

4. Artificial Pancreas - Pipeline Products under Development by Companies
4.1 Artificial Pancreas Companies - Pipeline Products by Stage of Development
4.2 Artificial Pancreas - Pipeline Products by Stage of Development

5. Artificial Pancreas Companies and Product Overview
5.1 Admetsys Corporation Company Overview
5.1.1 Admetsys Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.2 Advanced Biosensors-Ohio, Llc Company Overview
5.2.1 Advanced Biosensors-Ohio, Llc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Animas Corp Company Overview
5.3.1 Animas Corp Pipeline Products & Ongoing Clinical Trials Overview
5.4 Beta Bionics Inc Company Overview
5.4.1 Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Beta-O2 Technologies Ltd Company Overview
5.5.1 Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 Bigfoot Biomedical, Inc. Company Overview
5.6.1 Bigfoot Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.7 BioTex Inc Company Overview
5.7.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Cerco Medical LLC Company Overview
5.8.1 Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 Converge Biotech, Inc. Company Overview
5.9.1 Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.10 Covalor Medical, LLC Company Overview
5.10.1 Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 De Montfort University Company Overview
5.11.1 De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
5.12 Debiotech SA Company Overview
5.12.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
5.13 Defymed Inc Company Overview
5.13.1 Defymed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Diabeloop Company Overview
5.14.1 Diabeloop Pipeline Products & Ongoing Clinical Trials Overview
5.15 Giner Inc Company Overview
5.15.1 Giner Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Imperial College London Company Overview
5.16.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.17 Inreda Diabetic BV Company Overview
5.17.1 Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview
5.18 Insulet Corp Company Overview
5.18.1 Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
5.19 Kencak LLC Company Overview
5.19.1 Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview
5.20 Medtronic plc Company Overview
5.20.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Miromatrix Medical Inc Company Overview
5.21.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Nikkiso Co., Ltd. Company Overview
5.22.1 Nikkiso Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.23 Pacific Diabetes Technologies, Inc. Company Overview
5.23.1 Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.24 Pancreum, LLC Company Overview
5.24.1 Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.25 PharmaCyte Biotech Inc Company Overview
5.25.1 PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 Polytechnic University of Valencia Company Overview
5.26.1 Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
5.27 Rensselaer Polytechnic Institute Company Overview
5.27.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
5.28 Schneider Children's Medical Center of Israel Company Overview
5.28.1 Schneider Children's Medical Center of Israel Pipeline Products & Ongoing Clinical Trials Overview
5.29 Senseonics Holdings, Inc. Company Overview
5.29.1 Senseonics Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.30 TecMed, Inc. Company Overview
5.30.1 TecMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.31 The University of Newcastle Company Overview
5.31.1 The University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
5.32 TypeZero Technologies LLC Company Overview
5.32.1 TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.33 Ultradian Diagnostics LLC Company Overview
5.33.1 Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.34 Universidad Autonoma de Madrid Company Overview
5.34.1 Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview
5.35 University of California San Francisco Company Overview
5.35.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
5.36 University of California Santa Barbara Company Overview
5.36.1 University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
5.37 University of Cambridge Company Overview
5.37.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
5.38 University of Florida Company Overview
5.38.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.39 XERIS Pharmaceuticals Inc Company Overview
5.39.1 XERIS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

6. Artificial Pancreas - Recent Developments
6.1 Jul 26, 2017: PharmaCyte Biotech Appoints Dr. Linda S. Sher as Chief Medical Officer
6.2 Jul 10, 2017: PharmaCyte Biotech Appoints Dr. Michael M. Abecassis to Board of Directors
6.3 Jun 26, 2017: Medtronic Announces Outcomes-Based Agreement with Aetna for Type 1 and Type 2 Diabetes Patients
6.4 Jun 22, 2017: Phase 2a trial results support development of dasiglucagon in the iLet pump system for type 1 diabetes
6.5 Jun 12, 2017: Insulet Presents Positive Omnipod Horizon Hybrid Closed-Loop Study Results in Children
6.6 Jun 07, 2017: Medtronic Initiates U.S. Launch of World's First Hybrid Closed Loop System for Type 1 Diabetes
6.7 May 30, 2017: Insulet Appoints Bret Christensen as Chief Commercial Officer
6.8 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
6.9 May 08, 2017: Insulet Reports First Quarter 2017 Financial Results
6.10 May 02, 2017: PharmaCyte Biotech Appoints Thomas Yuen to Board of Directors
6.11 Apr 28, 2017: Artificial pancreas benefits young children, trial shows
6.12 Apr 20, 2017: Cellnovo announces that Diabeloop is launching a CE marking Registration Study on Artificial Pancreas with Cellnovo pump
6.13 Apr 19, 2017: PharmaCyte Biotech Receives the 2017 “Pipelines of Promise” Award from BIO International
6.14 Apr 03, 2017: PharmaCyte Biotech Appoints Dr. Mark Rabe Director of Cannabis Program Development
6.15 Mar 30, 2017: ConvaTec Expands Unomedical Manufacturing Technology Partnership with Medtronic Diabetes to Meet Growing Demand
6.16 Mar 13, 2017: PharmaCyte Biotech Names Dr. Leonard Makowka as Senior Strategic Advisor
6.17 Mar 06, 2017: Important Update On Minimed 670G Availability And The Priority Access Program
6.18 Feb 27, 2017: Insulet Reports Fourth Quarter and Full Year 2016 Financial Results
6.19 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
6.20 Feb 17, 2017: Insulet Presents Strong Omnipod Horizon Hybrid Closed-Loop Study Results at ATTD in Paris
6.21 Feb 13, 2017: National Institutes of Health Funds Schneider Children's Medical Center and International Diabetes Center Closed-Loop System Research
6.22 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
6.23 Jan 09, 2017: Xeris Pharmaceuticals Announces Appointment of Paul R. Edick as President and CEO
6.24 Jan 05, 2017: Cellnovo and Diabeloop Update on Artificial Pancreas
6.25 Dec 19, 2016: Bionic pancreas system successfully controls blood sugar without risk of hypoglycemia
6.26 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
6.27 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
6.28 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
6.29 Nov 03, 2016: Insulet Reports Third Quarter 2016 Financial Results
6.30 Oct 19, 2016: Insulet Announces Board and Management Changes
6.31 Sep 28, 2016: FDA approves first automated insulin delivery device for type 1 diabetes
6.32 Sep 15, 2016: The Journal of the American Medical Association Publishes Medtronic's Hybrid Closed Loop System Pivotal Trial Results
6.33 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
6.34 Sep 13, 2016: Insulet Enrolls First Patients in Clinical Trial for its Omnipod Artificial Pancreas System
6.35 Sep 06, 2016: Insulet to Establish Highly-Automated Manufacturing Operation in the United States
6.36 Sep 06, 2016: Insulet Announces Executive Appointments
6.37 Sep 05, 2016: Artificial pancreas trial in young children with diabetes receives €4.6millon grant from European Commission
6.38 Aug 25, 2016: Medtronic Reports First Quarter Financial Results

7. Appendix
7.1 Methodology
7.2 About
7.3 Contact Us
7.4 Disclaimer

1.1 List of Tables
Table 1: Artificial Pancreas - Pipeline Products by Stage of Development
Table 2: Artificial Pancreas - Pipeline Products by Territory
Table 3: Artificial Pancreas - Pipeline Products by Regulatory Path
Table 4: Artificial Pancreas - Pipeline Products by Estimated Approval Date
Table 5: Artificial Pancreas - Ongoing Clinical Trials
Table 6: Artificial Pancreas Companies - Pipeline Products by Stage of Development
Table 7: Artificial Pancreas - Pipeline Products by Stage of Development
Table 8: Admetsys Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Admetsys Smart Pancreas - Product Status
Table 10: Admetsys Smart Pancreas - Product Description
Table 11: Advanced Biosensors-Ohio, Llc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Artificial Pancreas - Product Status
Table 13: Artificial Pancreas - Product Description
Table 14: Animas Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Hypoglycemia-Hyperglycemia Minimizer System - Product Status
Table 16: Hypoglycemia-Hyperglycemia Minimizer System - Product Description
Table 17: Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: iLet - Product Status
Table 19: iLet - Product Description
Table 20: Beta Bionics Inc - Ongoing Clinical Trials Overview
Table 21: iLet - A Multicenter Study of Outpatient Automated Blood Glucose Control with a Bihormonal Bionic Pancreas
Table 22: iLet - Closed-loop Glucagon Administration for the Automated Prevention and Treatment of Hypoglycemia
Table 23: Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 24: ßAir Bio-artificial Pancreas - Product Status
Table 25: ßAir Bio-artificial Pancreas - Product Description
Table 26: Beta-O2 Technologies Ltd - Ongoing Clinical Trials Overview
Table 27: ßAir Bio-artificial Pancreas - An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets within the Bioartificial Pancreas Beta-Air in Patients with Type 1 Diabetes Mellitus
Table 28: Bigfoot Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Smartloop Automated Insulin Delivery System - Product Status
Table 30: Smartloop Automated Insulin Delivery System - Product Description
Table 31: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Artificial Pancreas - Product Status
Table 33: Artificial Pancreas - Product Description
Table 34: Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Islet Sheet - Product Status
Table 36: Islet Sheet - Product Description
Table 37: Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Bioartificial Pancreas System - Product Status
Table 39: Bioartificial Pancreas System - Product Description
Table 40: Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Artificial Pancreas - Product Status
Table 42: Artificial Pancreas - Product Description
Table 43: De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
Table 44: InSmart Artificial Pancreas - Product Status
Table 45: InSmart Artificial Pancreas - Product Description
Table 46: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Next Generation Artificial Pancreas - Product Status
Table 48: Next Generation Artificial Pancreas - Product Description
Table 49: Defymed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: MAILPAN - Product Status
Table 51: MAILPAN - Product Description
Table 52: Diabeloop Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Diabeloop Artificial Pancreas - Product Status
Table 54: Diabeloop Artificial Pancreas - Product Description
Table 55: Diabeloop - Ongoing Clinical Trials Overview
Table 56: Diabeloop Artificial Pancreas - Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop for Three Months at Home in Comparison with Conventional Treatment by External Insulin Pump in Patients with Type 1 Diabetes
Table 57: Giner Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 58: BAPIOS System - Product Status
Table 59: BAPIOS System - Product Description
Table 60: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Bio-inspired Artificial Pancreas - Product Status
Table 62: Bio-inspired Artificial Pancreas - Product Description
Table 63: Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Bi-Hormonal Artificial Pancreas - Product Status
Table 65: Bi-Hormonal Artificial Pancreas - Product Description
Table 66: Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Omnipod Horizon Hybrid Closed Loop System - Product Status
Table 68: Omnipod Horizon Hybrid Closed Loop System - Product Description
Table 69: Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 70: BioArtificial Pancreas - Product Status
Table 71: BioArtificial Pancreas - Product Description
Table 72: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 73: MiniMed 640G System - Product Status
Table 74: MiniMed 640G System - Product Description
Table 75: MiniMed 670G - Product Status
Table 76: MiniMed 670G - Product Description
Table 77: Third-Generation Artificial Pancreas System - Product Status
Table 78: Third-Generation Artificial Pancreas System - Product Description
Table 79: Medtronic plc - Ongoing Clinical Trials Overview
Table 80: MiniMed 670G - A Crossover Study Comparing Two Automated Insulin Delivery System Algorithms (PID vs. PID + Fuzzy Logic) in Adolescents and Young Adults with Type 1 Diabetes
Table 81: MiniMed 670G - Clinical Startup of the 670G Closed Loop Insulin Delivery System
Table 82: MiniMed 670G - Effect of Hybrid Closed-loop Insulin Delivery on Glucose Counterregulation in Long Standing Type 1 Diabetes: A Proof of Concept, Mechanistic, Single-arm Clinical Trial
Table 83: MiniMed 670G - Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes -Single-arm, Single-center, in Clinic Study-The DREAMED Trail
Table 84: MiniMed 670G - Multi-center, Randomized, Adaptive, Controlled Trial in Adult and Pediatric Patients with Type 1 Diabetes Using Hybrid Closed Loop System at Home
Table 85: MiniMed 670G - Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects with Type 1 Diabetes
Table 86: MiniMed 640G System - An Open-label, Multi-center, Randomized, 2-period Cross-over Study to Assess the Efficacy and Safety of Closed Loop Insulin Delivery Using Diluted Insulin in Comparison with Closed Loop with Non-diluted Insulin Over 21 Days in Children with Type 1 Diabetes Aged 1 to 7 Years in the Home Setting
Table 87: MiniMed 640G System - An Open-label, Multicenter, Randomized, Single-period, Parallel Design Study to Assess the Effect of Closed Loop Insulin Delivery from Onset of Type 1 Diabetes in Youth on Residual Beta Cell Function Compared to Standard Insulin Therapy
Table 88: MiniMed 640G System - Evaluation of Two Different Glucose Monitoring Treatments and Their Impact on Time in Target, Sleep and Quality of Life in Children with Type 1 Diabetes and Primary Caregivers
Table 89: MiniMed 640G System - Study of MiniMed 640G Insulin Pump With SmartGuard in Prevention of Low Glucose Events in Adults With Type 1 Diabetes
Table 90: MiniMed 640G System - Study of Minimed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes at Risk of Severe Hypoglycemia
Table 91: Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 92: Miro Pancreas - Product Status
Table 93: Miro Pancreas - Product Description
Table 94: Nikkiso Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 95: Artificial Pancreas - Product Status
Table 96: Artificial Pancreas - Product Description
Table 97: Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 98: Artificial Endocrine Pancreas - Product Status
Table 99: Artificial Endocrine Pancreas - Product Description
Table 100: Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 101: Genesis Artificial Pancreas - Product Status
Table 102: Genesis Artificial Pancreas - Product Description
Table 103: PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 104: Bio-Artificial Pancreas - Product Status
Table 105: Bio-Artificial Pancreas - Product Description
Table 106: Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
Table 107: ClosedLoop 4Meal Control - Product Status
Table 108: ClosedLoop 4Meal Control - Product Description
Table 109: Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 110: Closed-Loop Artificial Pancreas System - Product Status
Table 111: Closed-Loop Artificial Pancreas System - Product Description
Table 112: Schneider Children's Medical Center of Israel Pipeline Products & Ongoing Clinical Trials Overview
Table 113: MD-Logic Artificial Pancreas - Product Status
Table 114: MD-Logic Artificial Pancreas - Product Description
Table 115: Senseonics Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 116: Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump - Product Status
Table 117: Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump - Product Description
Table 118: Senseonics Holdings, Inc. - Ongoing Clinical Trials Overview
Table 119: Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump - Clinical Acceptance of the Artificial Pancreas: The International Diabetes Closed Loop (iDCL) Trial Research Site Training Protocol
Table 120: Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump - Clinical Acceptance of the Artificial Pancreas: The International Diabetes Closed Loop (iDCL) Trial: A Randomized Clinical Trial to Assess the Efficacy of Adjunctive Closed Loop Control Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes
Table 121: TecMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 122: TecMed Artificial Pancreas - Product Status
Table 123: TecMed Artificial Pancreas - Product Description
Table 124: The University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
Table 125: Closed Glucose-Sensing Insulin-Delivery System - Product Status
Table 126: Closed Glucose-Sensing Insulin-Delivery System - Product Description
Table 127: TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 128: inControl - Product Status
Table 129: inControl - Product Description
Table 130: TypeZero Technologies LLC - Ongoing Clinical Trials Overview
Table 131: inControl - Clinical Acceptance of the Artificial Pancreas: The International Diabetes Closed Loop (iDCL) Trial Research Site Training Protocol
Table 132: inControl - Clinical Acceptance of the Artificial Pancreas: The International Diabetes Closed Loop (iDCL) Trial: A Randomized Clinical Trial to Assess the Efficacy of Adjunctive Closed Loop Control Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes
Table 133: inControl - Examination of New Control Algorithm of inControl AP
Table 134: Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 135: Artificial Pancreas - Product Status
Table 136: Artificial Pancreas - Product Description
Table 137: Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview
Table 138: Predictive Rule-Based Algorithm - Product Status
Table 139: Predictive Rule-Based Algorithm - Product Description
Table 140: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
Table 141: Bioartificial Pancreas - Product Status
Table 142: Bioartificial Pancreas - Product Description
Table 143: University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
Table 144: Closed-Loop Artificial Pancreas - Product Status
Table 145: Closed-Loop Artificial Pancreas - Product Description
Table 146: Pediatric Artificial Pancreas - Product Status
Table 147: Pediatric Artificial Pancreas - Product Description
Table 148: University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
Table 149: Artificial Pancreas - Product Status
Table 150: Artificial Pancreas - Product Description
Table 151: Florence D2A System - Product Status
Table 152: Florence D2A System - Product Description
Table 153: University of Cambridge - Ongoing Clinical Trials Overview
Table 154: Florence D2A System - Closing the Loop in Adults with Type 1 Diabetes and HbA1C Less than 7.5% Under Free Living Conditions
Table 155: Artificial Pancreas - An Open-label, Multi-center, Randomized, 2-period Cross-over Study to Assess the Efficacy and Safety of Closed Loop Insulin Delivery Using Diluted Insulin in Comparison with Closed Loop with Non-diluted Insulin Over 21 Days in Children with Type 1 Diabetes Aged 1 to 7 Years in the Home Setting
Table 156: University of Florida Pipeline Products & Ongoing Clinical Trials Overview
Table 157: Bioartificial Pancreas - Type 1 Diabetes - Product Status
Table 158: Bioartificial Pancreas - Type 1 Diabetes - Product Description
Table 159: XERIS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 160: G-Pump - BP - Product Status
Table 161: G-Pump - BP - Product Description
Table 162: Glossary

1.2 List of Figures
Figure 1: Artificial Pancreas - Pipeline Products by Stage of Development
Figure 2: Artificial Pancreas - Pipeline Products by Territory
Figure 3: Artificial Pancreas - Pipeline Products by Regulatory Path
Figure 4: Artificial Pancreas - Pipeline Products by Estimated Approval Date
Figure 5: Artificial Pancreas - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Admetsys Corporation
  • Advanced Biosensors-Ohio, Llc
  • Animas Corp
  • Beta Bionics Inc
  • Beta-O2 Technologies Ltd
  • Bigfoot Biomedical, Inc.
  • BioTex Inc
  • Cerco Medical LLC
  • Converge Biotech, Inc.
  • Covalor Medical, LLC
  • De Montfort Univer
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll